Male Cancers
290 clinical trials
39 cell line models
7 approved drugs
Male Cancers
Molecular Synopsis
Drugs and clinical candidates

7 drugs have received FDA approval for Male Cancers:

  • Bleomycin Sulfate
  • Cisplatin
  • Dactinomycin
  • Etoposide
  • Etoposide Phosphate

113 drugs have a clinical trial registered for Male Cancers.

1195 compounds have been tested in Male Cancers (904 <= 500nM potency).

Sources:,, ChEMBL.

Clinical trials
There are 290 clinical trials for Male Cancers, 193 of which have one or more drug interventions, 97 with no drug intervention.
Cell line models

There are 39 Cell Line Models for Male Cancers.

Source: COSMIC
Cell line models

Please note the mappings below are based on an imperfect algorithm. If you notice any anomalies please report them to us.

The following terms have been mapped from mesh condition terms to Male Cancers:
  • Leydig Cell Tumor
  • Breast Neoplasms, Male
  • Testicular Neoplasms
  • Genital Neoplasms, Male
  • Sertoli-Leydig Cell Tumor
The following terms have been mapped from to Male Cancers:
  • Testicular cancer that has metastasized in patients who have already had surgery or radiation therapy
  • Penile cancer
  • Testicular cancer
  • Testicular cancer. It is used for nonseminomas that have metastasized (spread to other parts of the body)
  • Testicular cancer. It is used in patients who have already been treated with surgery, radiation therapy, or other chemotherapy and have not gotten better